IGF2BP2 and renal cell carcinoma: For both univariate and multivariate independent prognostic analysis, the risk score based on the expression level of SLC16A12, SLC2A9, IGF2BP2, EMX2, ANK3, and METTL7A are considered to be highly correlated with the prognosis of RCC patients.